Editors, Publishers, Impact Factors, and Reprint Income
article has not abstract
Vyšlo v časopise:
Editors, Publishers, Impact Factors, and Reprint Income. PLoS Med 7(10): e32767. doi:10.1371/journal.pmed.1000355
Kategorie:
Perspective
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000355
Souhrn
article has not abstract
Zdroje
1. LundhA
BarbateskovicM
HróbjartssonA
GøtzschePC
2010 Conflicts of interest at medical journals: The influence of industry-supported randomised trials on the journal impact factor. PLoS Med 7 e354 doi:10.1371/journal.pmed.1000354
2. ConenD
TorresJ
RidkerPM
2008 Differential citation rates of major cardiovascular clinical trials according to source of funding: a survey from 2000 to 2005. Circulation 118 1321 1327
3. KulkarniAV
BusseJW
ShamsI
2007 Characteristics associated with citation rate of the medical literature. PLoS ONE 2 e403 doi:10.1371/journal.pone.0000403
4. BhaudariM
BusseJ
DevereauxPJ
MontoriVM
SwiatkowskiM
2007 Factors associated with citation rates in the orthopaedic literature. Can J Surg 50 119 123
5. PhillipsDP
KanterEJ
BednarczykB
TastadPL
1991 Importance of the lay press in the transmission of medical knowledge to the scientific community. N Eng J Med 325 1180 1183
6. ChapmanS
NguyenTN
WhiteC
2006 Press-released papers are more downloaded and cited. Tob Control 16 71
7. RossJ
HillKP
EgilmanDS
KrumholzH
2008 Guest authorship and ghost writing in publications related to Rofecoxib: a case study of industry documents from Rofecoxib litigation. JAMA 299 1800 1812
8. LexchinJ
BeroLA
DjulbegovicB
ClarkO
2003 Pharmaceutical industry sponsorship and research outcome and quality: a systematic review. BMJ 326 1167 1170
9. FontanarosaPB
FlanaginA
DeAngelisCD
2005 Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA 294 110 111
10. RothmanDJ
McDonaldWJ
BerkowitzCD
ChimonasSC
DeAngelisCD
2009 Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA 301 1367 1372
11. Scott-Lichter D and the editorial policy committee, Council of Science Editors CSE's white paper on promoting integrity in scientific journal publications, 2009 update, Reston, Va: 2009. Available: http://www.councilscienceeditors.org/i4a/pages/index.cfm?pageid=3354#2.1.3. Accessed 24 September 2010
12. AngellM
January 15, 2009 Drug companies and doctors: A story of corruption. The New York Review of Books 56. Available: http://www.nybooks.com/articles/archives/2009/jan/15/drug-companies-doctorsa-story-of-corruption/. Accessed 20 September 2010
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 10
- Statinová intolerance
- Hydroresponzivní krytí v epitelizační fázi hojení rány
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Epigenetic Epidemiology of Common Complex Disease: Prospects for Prediction, Prevention, and Treatment
- Editors, Publishers, Impact Factors, and Reprint Income
- Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project
- The Persisting Burden of Intracerebral Haemorrhage: Can Effective Treatments Be Found?